Biotechnology Stocks I Performance Guide: Ultragenyx Pharmaceutical Inc. (RARE)
RARE has no dividends.
Table and Chart of RARE Performance
See what a $1,000 investment in RARE is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| RARE Returns | |
|---|---|
| Start Date | May-30-2014 |
| Start Price | $37.56 |
| End Date | May-07-2024 |
| End Price | $41.96 |
| # Prices | 121 |
| Min Date | Oct-31-2023 |
| Min Price | $35.40 |
| Max Date | Feb-26-2021 |
| Max Price | $141.54 |
| Total Return | 11.71% |
| Annualized Return | 1.10% |
| Current Value of $1,000 Purchase | $1,117 |
| Number Returns | 7,260 |
| Average Return | 3.69% |
| Number Profitable Returns | 3,073 |
| Percent Profitable Returns | 42.33% |
| Number Unprofitable Returns | 4,187 |
| Percent Unprofitable Returns | 57.67% |
| Profitable to Unprofitable Returns Ratio | 0.73 |
| RARE Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $3,575,563,000 |
| Beta | 0.658 | Price to Sales | 8.91 |
| Earnings per Share | $-7.9500 |
| PE Ratio | None |
| PE to Growth Ratio | -0.24 |
| Price to Book | 14.05 |
| PRICE DATA | |
| 52 Week High | $54.98 |
| 52 Week Low | $31.52 |
| Analyst Target Price | $88.85 |
| 50-Day Moving Average | $47.31 |
| 200-Day Moving Average | $42.1 |
| FINANCIAL DATA | |
| Revenue per Share | $5.75 |
| Revenue | $442,586,000 |
| Profit Margin | -138.6% |
| Return on Equity | -340.1% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
RARE Compare Returns with S&P 500
RARE Trendline Chart
RARE Moving Average Chart
RARE Stock Return Map - See Patterns of Gains and Losses
RARE Stock Returns/Purchase Dates